Dr. Charles Lopez
I've won the following awards
Top Doctors, Portland Monthly Magazine
Rose Award for Exemplary Clinical Service, Oregon Health and Science University
New insights into the expanding complexity of the tumor suppressor ASPP2.
Cell Cycle., Sep;8(18):2871-6 (2009)
Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds.
Proc. Natl. Acad. Sci. U.S.A., Mar;106(11):4390-5 (2009)
E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair.
J. Biol. Chem., May;283(22):15381-9 (2008)
hADA2a and hADA3: new players in beta-catenin signaling.
Cancer Biol. Ther., Jan;7(1):129-30 (2008)
The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells.
Cancer Res., Apr;66(7):3485-94 (2006)
Control of ASPP2/(53BP2L) protein levels by proteasomal degradation modulates p53 apoptotic function.
J. Biol. Chem., Oct;280(41):34473-80 (2005)
Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
Cell Death Differ., Apr;12(4):358-68 (2005)
Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.
Oncogene., Nov;21(51):7901-11 (2002)
Inhibition of cell death by ribosomal protein L35a.
Cancer Lett., Jun;180(2):195-202 (2002)